109 related articles for article (PubMed ID: 36884352)
21. Optimized mesoporous silica nanoparticle-based drug delivery system with removable manganese oxide gatekeeper for controlled delivery of doxorubicin.
Miao Y; Feng Y; Bai J; Liu Z; Zhao X
J Colloid Interface Sci; 2021 Jun; 592():227-236. PubMed ID: 33662827
[TBL] [Abstract][Full Text] [Related]
22. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
Li J; Du X; Zheng N; Xu L; Xu J; Li S
Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288
[TBL] [Abstract][Full Text] [Related]
23. YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells.
Liu Z; Tao Z; Zhang Q; Wan S; Zhang F; Zhang Y; Wu G; Wang J
Cancer Chemother Pharmacol; 2018 Apr; 81(4):687-695. PubMed ID: 29392452
[TBL] [Abstract][Full Text] [Related]
24. Nanoplatform based on GSH-responsive mesoporous silica nanoparticles for cancer therapy and mitochondrial targeted imaging.
He H; Meng S; Li H; Yang Q; Xu Z; Chen X; Sun Z; Jiang B; Li C
Mikrochim Acta; 2021 Apr; 188(5):154. PubMed ID: 33821295
[TBL] [Abstract][Full Text] [Related]
25. Drug molecules bridge with small gatekeeper to co-block mesoporous silica nanoparticles for drug delivery.
Li R; Feng C; Yang R; Li X; Ruan L
Colloids Surf B Biointerfaces; 2022 May; 213():112350. PubMed ID: 35151045
[TBL] [Abstract][Full Text] [Related]
26. Smart MSN-Drug-Delivery System for Tumor Cell Targeting and Tumor Microenvironment Release.
Dong JH; Ma Y; Li R; Zhang WT; Zhang MQ; Meng FN; Ding K; Jiang HT; Gong YK
ACS Appl Mater Interfaces; 2021 Sep; 13(36):42522-42532. PubMed ID: 34463488
[TBL] [Abstract][Full Text] [Related]
27. Ofloxacin@Doxorubicin-Epirubicin functionalized MCM-41 mesoporous silica-based nanocarriers as synergistic drug delivery tools for cancer related bacterial infections.
Galhano J; Marcelo GA; Duarte MP; Oliveira E
Bioorg Chem; 2022 Jan; 118():105470. PubMed ID: 34814085
[TBL] [Abstract][Full Text] [Related]
28. Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy.
Lei W; Sun C; Jiang T; Gao Y; Yang Y; Zhao Q; Wang S
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110103. PubMed ID: 31546357
[TBL] [Abstract][Full Text] [Related]
29. Membrane-cloaked polydopamine modified mesoporous silica nanoparticles for cancer therapy.
Wang Z; Shi J; Pan H; Liu M; Sang Y; Ai J; Liu Y; Chen L
Nanotechnology; 2022 Jun; 33(34):. PubMed ID: 35576909
[TBL] [Abstract][Full Text] [Related]
30. Multifunctional mesoporous silica nanoparticles as efficient transporters of doxorubicin and chlorin e6 for chemo-photodynamic combinatorial cancer therapy.
Sun JH; Zhang W; Zhang DY; Shen J; Tan CP; Ji LN; Mao ZW
J Biomater Appl; 2018 Apr; 32(9):1253-1264. PubMed ID: 29448866
[TBL] [Abstract][Full Text] [Related]
31. Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis.
Dong K; Zhao ZZ; Kang J; Lin LR; Chen WT; Liu JX; Wu XL; Lu TL
Int J Nanomedicine; 2020; 15():10285-10304. PubMed ID: 33376322
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional PEG modified DOX loaded mesoporous silica nanoparticle@CuS nanohybrids as photo-thermal agent and thermal-triggered drug release vehicle for hepatocellular carcinoma treatment.
Wu L; Wu M; Zeng Y; Zhang D; Zheng A; Liu X; Liu J
Nanotechnology; 2015 Jan; 26(2):025102. PubMed ID: 25517859
[TBL] [Abstract][Full Text] [Related]
33. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment.
Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM
Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156
[TBL] [Abstract][Full Text] [Related]
34. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application.
Teng X; Cheng S; Meng R; Zheng S; Yang L; Ma Q; Jiang W; He J
J Nanosci Nanotechnol; 2015 May; 15(5):3773-9. PubMed ID: 26505004
[TBL] [Abstract][Full Text] [Related]
35. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
[TBL] [Abstract][Full Text] [Related]
36. Preparation of multifunctional mesoporous SiO
Wu Y; Sun Z; Song J; Mo L; Wang X; Liu H; Ma Y
Nanotechnology; 2022 Nov; 34(5):. PubMed ID: 36317264
[TBL] [Abstract][Full Text] [Related]
37. Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging.
Croissant JG; Zhang D; Alsaiari S; Lu J; Deng L; Tamanoi F; AlMalik AM; Zink JI; Khashab NM
J Control Release; 2016 May; 229():183-191. PubMed ID: 27016140
[TBL] [Abstract][Full Text] [Related]
38. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J
Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125
[TBL] [Abstract][Full Text] [Related]
39. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
40. Co-responsive smart cyclodextrin-gated mesoporous silica nanoparticles with ligand-receptor engagement for anti-cancer treatment.
Wu Y; Xu Z; Sun W; Yang Y; Jin H; Qiu L; Chen J; Chen J
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109831. PubMed ID: 31349481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
